HLUYY Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 01:00):

Stats
Tagesvolumen	7 539.00
Durchschnittsvolumen	1 786.00
Marktkapitalisierung	0.00
Last Dividend	$0.204 ( 2022-03-24 )
Next Dividend	$0 ( N/A )
P/E	28.95
ATR14	$2.36 (10.72%)

H. Lundbeck A/S Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

H. Lundbeck A/S Finanzdaten

Annual	2021
Umsatz:	$16.30B
Bruttogewinn:	$12.65B (77.62 %)
EPS:	$0

FY	2021
Umsatz:	$16.30B
Bruttogewinn:	$12.65B (77.62 %)
EPS:	$0

FY	2020
Umsatz:	$17.67B
Bruttogewinn:	$13.50B (76.42 %)
EPS:	$7.95

FY	2019
Umsatz:	$17.36B
Bruttogewinn:	$13.97B (80.50 %)
EPS:	$13.42

Financial Reports:

No articles found.

H. Lundbeck A/S Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

H. Lundbeck A/S Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$0.350	2013-03-22
Last Dividend	$0.204	2022-03-24
Next Dividend	$0	N/A
Payout Date	2022-04-05
Next Payout Date	N/A
# dividends	8	--
Total Paid Out	$4.94	--
Avg. Dividend % Per Year	0.00%	--
Score	0.28	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-10-14)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

0.28

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
RCBC	Ex Dividend Junior	2023-07-31	Quarterly	0.00%
FABP	Ex Dividend Knight	2023-07-31	Quarterly	0.00%
VTKLY	Ex Dividend Knight	2023-07-20	Semi-Annually	0.00%
LGRDY	Ex Dividend Junior	2023-05-31	Annually	0.00%
CHDRY	Ex Dividend Knight	2023-12-04	Semi-Annually	0.00%
SFRGY	Ex Dividend Junior	2023-05-22	Annually	0.00%
GBOOY	Ex Dividend Knight	2023-06-15	Annually	0.00%
AGRIP	Ex Dividend Knight	2023-08-31	Quarterly	0.00%
MUEL	Ex Dividend Junior	2023-08-28	Sporadic	0.00%
CNPWP	Ex Dividend Knight	2023-07-07	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0	1.500	-1.111	-1.667	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.977	0.800	-0.117	-0.0934	[1 - 3]
quickRatioTTM	0.258	0.800	-3.19	-2.55	[0.8 - 2.5]
cashRatioTTM	0.258	1.500	9.68	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	13.14	1.000	6.25	6.25	[3 - 30]
operatingCashFlowPerShareTTM	3.08	2.00	8.97	10.00	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.776	1.000	0.397	0.397	[0.2 - 0.8]
operatingProfitMarginTTM	0.123	1.000	9.53	9.53	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.41

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	0	1.000	-0.101	0	[1 - 100]
returnOnEquityTTM	0	2.50	-0.714	-1.667	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.08	2.00	8.97	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0375	1.000	-1.561	0	[0.1 - 0.5]
Total Score				0.155

H. Lundbeck A/S

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.